He ended up more confused than when he started. Which was ironic, because HbA1c is one of the most useful metabolic tests available — if the number is actually understood: what it measures, what its limitations are, how to act on the result.
This guide exists to clear that confusion out. Not to hand over a target number to fixate on, but to explain what the test is actually saying about three months of blood sugar history, what the number means across the full spectrum from optimal to diabetic, and how to use it as one data point inside a broader metabolic picture.
What HbA1c Actually Measures
Hemoglobin A1c — glycated hemoglobin — measures how much glucose has bound to hemoglobin molecules in red blood cells over the preceding two to three months. The test exploits a basic piece of blood sugar chemistry: circulating glucose spontaneously and irreversibly attaches to proteins throughout the body through a non-enzymatic process called glycation. Hemoglobin, the oxygen-carrying protein in red blood cells, is one of those proteins, and the percentage of hemoglobin that’s been glycated reflects the average glucose concentration those cells have been swimming in during their lifespan.
Red blood cells live roughly 90-120 days. That’s why this reflects a two-to-three-month average rather than a snapshot — every red blood cell currently in circulation has been accumulating glycation since it formed, and the population of cells at any given moment spans the last three months of blood sugar exposure. Older cells (formed when blood sugar was different) contribute proportionally less to the current reading as they get replaced, which makes HbA1c a weighted average leaning somewhat more toward the most recent month than the earlier ones.
The test reports as a percentage: HbA1c of 5.7% means roughly 5.7% of hemoglobin molecules in the blood have been glycated. That percentage maps to an estimated average glucose concentration — the “estimated average glucose” (eAG) that many labs now report alongside it. An HbA1c of 5.7% corresponds to an eAG of roughly 117 mg/dL; 6.5% to roughly 140 mg/dL; 7.0% (the conventional diabetes management target) to roughly 154 mg/dL.
The test is standardized across labs to a degree most blood tests aren’t — a result from one lab should be comparable to a result from another, assuming both use modern assay methods. That standardization makes it useful for tracking trends over time across different testing settings, which matters for anyone who changes healthcare providers or travels a lot.
The Full HbA1c Range: Optimal to Diabetic
The conventional diagnostic thresholds — below 5.7% normal, 5.7-6.4% prediabetes, 6.5% and above diabetes — are population-based risk cutpoints, not biological on-off switches. The risk of metabolic complications runs on a continuous gradient. The cutpoints are conventions, not sharp clinical lines.
Below 5.0%: this range tracks with the lowest rates of cardiovascular disease, Alzheimer’s disease, and metabolic disease in epidemiological research. A comprehensive analysis of this and cardiovascular risk found values below 5.0% associated with the lowest hazard ratios across multiple disease outcomes. People with HbA1c here tend to be metabolically healthy, physically active, with good insulin sensitivity. Not a universal target — dropping below 5.0% through dietary restriction that causes other nutritional deficiencies isn’t a net win — but it’s the level tied to optimal metabolic health outcomes in observational data.
5.0-5.4%: still excellent range. Metabolic disease risk is low. No urgent intervention needed, though maintaining whatever produced this level is worthwhile.
5.5-5.6%: territory where metabolic health deserves active monitoring and maintenance. Risk begins rising measurably above the below-5.0% baseline. This was Michael’s range — a number that shouldn’t get dismissed as “fine,” but also shouldn’t get catastrophized. An early signal worth taking seriously. Not a crisis.
5.7-6.4% (prediabetes range): clinically significant elevated risk. As covered in the prediabetes reversal guide, this range has established lifestyle interventions that cut progression risk by 58% (intensive lifestyle) or 31% (metformin). People here need a concrete action plan, not just monitoring.
6.5% and above (diabetes range): type 2 diabetes diagnosis. Management at this level requires medical oversight, typically a combination of lifestyle intervention, glucose monitoring, and often pharmaceutical management depending on severity and beta cell function status. This guide doesn’t cover management at the diabetes end of the spectrum — that needs individualized clinical care.
The Limitations of HbA1c: What the Test Misses
HbA1c is a useful test, but it carries several limitations that can push the result too high or too low in specific populations. Understanding these determines when additional testing is needed and when to trust the result at face value.
Hemoglobin variants: several genetic variants of hemoglobin (hemoglobin S, C, E, and others) mess with the assay in ways that can throw off the result. Sickle cell trait (hemoglobin S, common in people of African, Mediterranean, and Middle Eastern ancestry) can produce falsely low readings. Some assay methods handle hemoglobin variants better than others; modern HPLC-based assays are generally more accurate in people with common variants, but the specific assay a given lab uses matters. Anyone of African, Mediterranean, Middle Eastern, or Asian heritage with family history of hemoglobin variants should keep this limitation in mind.
Anemia and conditions affecting red blood cell lifespan: the test reflects glucose exposure over the lifespan of red blood cells. Conditions that shorten that lifespan (hemolytic anemia, blood transfusions, iron deficiency anemia in some presentations) reduce the average age of circulating cells and produce falsely low readings. Conditions that extend it (iron deficiency causing reduced red blood cell production, some kidney disease presentations) can push readings falsely high. Anyone with anemia or red blood cell disorders should treat HbA1c as potentially unreliable and look at alternative tests.
The averaging problem: the test represents an average across three months. Someone with consistently moderate blood sugar elevation posts the same HbA1c as someone with wildly fluctuating blood sugar — alternating hypoglycemia and hyperglycemia — whose readings average out to the same level. The second person is experiencing more glycation (higher peaks) and potentially more hypoglycemic events (lower troughs), both tied to worse outcomes, but the HbA1c looks identical either way. This is the gap continuous glucose monitoring fills: it reveals the shape of the glucose curve rather than just the average, information the test alone cannot provide.
The two-to-three-month lag: HbA1c reflects the past, not the present. Someone who made a dramatic lifestyle change two months ago may still show an HbA1c reflecting the three months before the change. That creates a practical issue (an early result doesn’t reflect current metabolic state) and a motivation-management challenge (improvements lag behavioral change by weeks to months). The right follow-up interval after a major lifestyle change is three to four months — test sooner, and the improvement won’t have fully shown up yet.
Fructosamine: The Alternative When HbA1c Falls Short
When HbA1c is unreliable — hemoglobin variants, anemia, or the need for a shorter assessment window — fructosamine offers an alternative measure of average blood glucose.
Fructosamine measures glycated serum proteins — mainly albumin, which lives roughly two to three weeks rather than the red blood cell’s two to three months. That means fructosamine reflects average blood glucose over roughly two to three weeks, compared to HbA1c’s two-to-three-month window. A shorter-term snapshot, which is both its limitation (less representative of long-term glucose control) and its advantage (reflects recent changes faster, not tangled up in red blood cell lifespan variables).
The normal fructosamine range typically runs 200-285 umol/L, higher values meaning higher average blood glucose. The test is less standardized across labs than HbA1c and somewhat less common in clinical practice, but it’s available at most major reference labs and can be ordered by a physician when HbA1c reliability is in question.
For most people, fructosamine isn’t a replacement for HbA1c but a supplementary test used when specific circumstances make HbA1c unreliable. Worth knowing it exists — useful for the relatively small slice of people whose HbA1c interpretation gets complicated by the conditions above.
HbA1c in Context: Building the Complete Metabolic Picture
HbA1c is one piece of a metabolic health assessment, not the complete picture. Understanding what tests complement it produces a far more informative read on glucose regulation and metabolic health.
Fasting insulin, covered extensively in the insulin resistance guide, shows how hard the pancreas is working to hold the glucose level HbA1c reflects. A normal HbA1c with high fasting insulin means glucose is under control, but only through excessive insulin output — a sign of significant insulin resistance that will eventually progress if the behavioral drivers go unaddressed. A normal HbA1c with low fasting insulin means insulin sensitivity is good and the pancreas is managing efficiently.
HOMA-IR (calculated from fasting glucose and fasting insulin) delivers the composite insulin resistance score. This one calculation, built from two widely available tests, says more about underlying metabolic health than HbA1c alone. A HOMA-IR above 2.5 with normal HbA1c signals significant insulin resistance being compensated by hyperinsulinemia — the classic early metabolic disease pattern that HbA1c misses entirely.
Fasting triglycerides and HDL cholesterol round out the primary metabolic picture. The triglyceride-to-HDL ratio is a sensitive marker of insulin resistance and hepatic metabolic function. Elevated triglycerides with low HDL signals dyslipidemia driven by insulin resistance, often showing up before any HbA1c elevation does. A normal HbA1c with a triglyceride-to-HDL ratio above 3.5 signals metabolic dysfunction HbA1c alone would miss.
The complete metabolic panel for a meaningful assessment: fasting glucose, HbA1c, fasting insulin (less commonly tested but highly informative), triglycerides, HDL. Five values that tell a complete story about glucose regulation, insulin sensitivity, and metabolic disease trajectory — a story no single test can tell alone. For the most comprehensive picture, add fasting LDL particle number or ApoB (more informative than standard LDL-C), C-reactive protein (inflammation marker), and uric acid (insulin resistance marker and independent cardiovascular risk factor).
HbA1c Trends: What Matters More Than Any Single Number
A single HbA1c result says where someone is. Annual or biannual results say where they’re going. The trajectory usually matters more clinically than any individual value.
An HbA1c stable at 5.3% for five years describes a metabolically stable person whose behaviors are holding glucose control steady. An HbA1c that was 5.0% three years ago, 5.3% two years ago, 5.5% last year, and 5.6% this year describes someone on a metabolic deterioration trajectory — even though this year’s 5.6% is technically still “normal,” the trend flags a person whose metabolic health is actively declining, likely to cross into prediabetic range within a few more years without intervention.
This trend analysis is the strongest argument for testing HbA1c regularly through adult life rather than waiting for symptoms or clinical thresholds to prompt it. The data series matters more than any individual point. Most physicians won’t track an HbA1c trend unless already in the prediabetic or diabetic range — standard of care is to start monitoring after diagnostic thresholds are crossed, not before. Which means tracking your own data and evaluating your own trend, having the tests done proactively and keeping records over time.
A spreadsheet with annual results — date, HbA1c, fasting glucose, fasting insulin, triglycerides, HDL — serves as a personal metabolic longitudinal study. It catches trends invisible in any single annual snapshot, makes it possible to evaluate whether lifestyle changes are producing the intended improvements, and provides the historical context that makes any individual result interpretable rather than isolated.
The HbA1c Action Guide Framework
The framework for responding to HbA1c results organizes the appropriate action by result range — specific, evidence-based responses rather than generic advice.
HbA1c below 5.0% — Maintenance protocol: excellent. Document this as a baseline. Continue whatever’s producing this level. Retest annually. No intervention needed beyond maintaining current practice.
HbA1c 5.0-5.4% — Monitor and optimize: good result. If trending upward from previous tests, identify and address the behavioral drift — diet, exercise, sleep, stress. If stable across multiple tests, maintain current practices. Test every one to two years. Add fasting insulin to the next test to assess underlying insulin sensitivity.
HbA1c 5.5-5.6% — Early intervention signal: Michael’s range. Not an emergency, but a signal that warrants active response rather than monitoring alone. Get a complete metabolic panel (fasting insulin, triglycerides, HDL added in). Implement dietary quality improvements — eliminate ultra-processed foods, added sugars, refined grains. Begin consistent post-meal walking. Optimize sleep. Retest in three to four months to check the trend response. If the next result is higher, escalate to the prediabetes reversal protocol.
HbA1c 5.7-6.4% — Prediabetes reversal protocol: full implementation of the 90-day prediabetes reversal protocol in the companion guide. Discuss with a physician. Consider whether metformin fits as an adjunct, particularly at the higher end of this range. Retest every three months during active reversal. Track the complete metabolic panel alongside HbA1c.
HbA1c 6.5% and above — Medical management: type 2 diabetes diagnosis. Requires physician-supervised management. Lifestyle intervention remains foundational and more effective than medications alone across multiple studies, but the clinical complexity here warrants professional oversight. The interventions in this cluster of guides are appropriate and evidence-based, but implementation should happen alongside a physician who can monitor complications risk and medication interactions.
Common Questions About HbA1c Explained Number
- How often should I get HbA1c tested? Annual testing is appropriate for adults with no current metabolic concerns. People in the 5.5-5.6% range should test every six months until the trend stabilizes or improves. People in the prediabetes range (5.7-6.4%) during active lifestyle intervention should test every three months to track progress. People who’ve achieved reversal and returned to normal range should test every six to twelve months to watch for regression.
- Can HbA1c change quickly? Yes, meaningfully — HbA1c can fall 0.3-0.5% within 90 days of significant dietary and lifestyle change, though the full effect of interventions can take three to six months to show up fully in the test, thanks to the averaging effect described earlier. Anyone seeing no HbA1c change after three months of genuine lifestyle intervention should check whether the interventions are actually being implemented consistently, or whether additional dietary changes are needed.
- Is HbA1c 5.7% always prediabetes? By American Diabetes Association criteria, yes. By some other national and international standards, the prediabetes threshold sits at 6.0% HbA1c, which would make a 5.7% result normal. The ADA threshold runs more conservative (more sensitive for catching early disease) at the cost of being less specific (more false positives). Practically: a 5.7% HbA1c is a signal for lifestyle optimization no matter which country’s threshold applies. Labeled “prediabetes” or “high normal,” the right response is the same — improve metabolic health rather than hope the label is wrong.
- What causes a sudden HbA1c increase between annual tests? Common culprits: weight gain (particularly visceral fat), a significant drop in physical activity, worsening sleep quality or duration, major psychological stress (via cortisol’s effects on glucose metabolism), dietary shifts toward more processed foods or added sugars, and new medications affecting glucose metabolism (corticosteroids, some antipsychotics, some antiretrovirals). Identifying which of these shifted in the preceding three to twelve months usually finds the primary driver.
- Can HbA1c be too low? Yes, though rare in non-diabetics. HbA1c below 4.0% can indicate chronic hemolysis (accelerated red blood cell destruction) or another condition affecting red blood cell lifespan, producing falsely low values. In diabetics on insulin therapy, a very low HbA1c may reflect excessive insulin use with frequent hypoglycemic episodes. In healthy non-diabetics, HbA1c doesn’t typically drop below 4.5% even with optimal metabolic health, so values below that range warrant investigation for the conditions above.
- Should I fast before an HbA1c test? No. Unlike fasting glucose or fasting insulin, HbA1c doesn’t require fasting — it measures cumulative glycation of red blood cells, not acute blood glucose. Eating normally beforehand is fine. The test typically gets combined with fasting glucose on a standard metabolic panel, which does require fasting — so the practical move is to fast for the full panel including both tests, then eat afterward, rather than ending up with HbA1c drawn fasting and glucose drawn fed or the reverse.
- What’s the relationship between HbA1c and aging? HbA1c tends to creep up slowly with age even in metabolically healthy populations, for reasons not fully explained — possible contributors include age-related changes in red blood cell turnover, mild age-related decline in glucose regulation, and cumulative exposure to dietary glycation products. This age association means an HbA1c of 5.5% carries different implications for a 30-year-old (potentially early metabolic dysfunction) versus a 75-year-old (within age-expected range for many longitudinal studies). Age-adjusted reference ranges aren’t standardly reported but should factor into interpretation, particularly at the margins of clinical thresholds.
- How accurate is the relationship between HbA1c and average glucose? The eAG calculation from HbA1c assumes a standard relationship between glycation and average glucose concentration. That relationship holds well at the population level but carries significant individual variation — some people glycate hemoglobin at higher or lower rates than average, so their HbA1c over- or underestimates true average glucose. High glycators (above-average glycation rate) end up with HbA1c values that look more concerning than their actual glucose levels warrant. Low glycators get falsely reassuring HbA1c results relative to true glucose exposure. One more reason CGM data adds something HbA1c can’t — it measures actual glucose rather than a proxy derived from glycation rates.
Michael retested his HbA1c six months after his 5.6% reading, having added post-meal walks, eliminated his daily soda and energy drinks, started sleeping seven hours instead of five, and done three resistance training sessions weekly. His result was 5.2%. His doctor said “looks good, see you next year.” Michael took a different lesson from it: a decimal-point change on a lab report represented months of genuine behavioral change. He understood now what the number meant, what it reflected, and what it didn’t tell him. He added fasting insulin to his annual panel. He kept testing. He stopped being confused. That was the whole point.
HbA1c is not a verdict. It’s a signal. A number reflecting three months of biological history, imperfectly, with known limitations and known context. Its value isn’t the anxiety it can generate when a result crosses a threshold — it’s the data it provides for making informed decisions about metabolic health, decisions that, applied consistently over years, compound into meaningfully different health trajectories.
Know the number. Understand its context. Act on the trend, not the panic. And combine it with the additional tests that give it full meaning — because a number in isolation is a data point, but a number in context is a diagnosis, a direction, and a plan.
HbA1c and Cardiovascular Risk: Beyond Diabetes Prediction
Most people think of HbA1c purely as a diabetes test. Its predictive value for cardiovascular disease is less commonly appreciated, despite being well-established in the literature.
A landmark 2011 meta-analysis in BMJ, pulling data from 102 prospective studies covering over 300,000 participants without known diabetes, found HbA1c a significant predictor of coronary heart disease and stroke events, with risk rising continuously across the range even below the diabetic threshold. People with HbA1c between 5.0-5.5% had meaningfully higher cardiovascular event rates than those below 5.0%, and the gradient kept climbing through the prediabetic range.
This finding reframes HbA1c as a cardiovascular risk assessment tool, not just a diabetes screening test. The same glycation processes that damage beta cells over time also damage arterial endothelium, promote advanced glycation end product accumulation in arterial walls, and contribute to atherosclerotic plaque progression. The HbA1c number reflects not just how much glucose damage is being done to the pancreas, but how much is being done to every blood vessel, every nerve ending, every other tissue exposed to circulating glucose.
This matters for people who think “no diabetes in my family, I’m not at risk” — anyone with HbA1c in the 5.5-5.9% range might carry meaningful cardiovascular risk that cholesterol panels and blood pressure readings alone would miss. HbA1c adds cardiovascular risk information rather than duplicating it — it’s additive to traditional cardiovascular risk factors, not redundant with them. Folding it into a standard cardiovascular risk assessment produces a more complete picture than either alone.
Special Populations: HbA1c Interpretation in Context
Certain populations need extra nuance in HbA1c interpretation beyond the standard reference ranges.
People of Asian ethnicity develop diabetes-related complications at lower HbA1c and BMI thresholds than European populations. A South Asian person with an HbA1c of 5.9% may carry a higher absolute risk of complications than a person of European ancestry at the same value — partly due to higher visceral fat-to-total fat ratios at equivalent body weights, and different genetic factors in insulin secretion. Some diabetes organizations recommend lower thresholds for prediabetes and diabetes diagnosis in Asian populations.
Pregnant women run lower normal HbA1c ranges due to increased red blood cell turnover and physiological changes in glucose metabolism. Diagnostic thresholds for gestational diabetes management differ from standard diabetes thresholds and get managed within obstetric care frameworks.
Older adults (above 70) often see HbA1c values inch upward with age even with stable metabolic health, as noted earlier. Aggressive HbA1c lowering in elderly patients through medications can paradoxically raise cardiovascular event rates, thanks to hypoglycemia risk — a finding that’s modified diabetes management guidelines to allow higher HbA1c targets in older patients. The optimal HbA1c range for longevity in the elderly appears slightly higher than for younger adults, and the risks of very low HbA1c (from hypoglycemia) may outweigh the benefits at advanced age.
Athletes with very high training volumes may run slightly lower HbA1c values than sedentary peers on equivalent dietary patterns, due to higher muscle glucose uptake and lower average blood glucose from increased insulin sensitivity. A serious endurance athlete whose HbA1c seems notably lower than other metabolic markers would predict — benign explanation, not a cause for concern.
How to Use HbA1c as a Behavioral Feedback Tool
The most practical use of HbA1c, beyond diagnosis and risk assessment, is as a quarterly feedback mechanism for checking whether metabolic behaviors are producing the intended effect on blood sugar management. Used this way, HbA1c is less about the number itself and more about the trajectory it reveals in response to specific behavioral changes.
Make a significant dietary change — cutting sugary beverages, reducing refined carbohydrates, implementing time-restricted eating — and want to know if it’s actually improving glucose control? A follow-up HbA1c test at 90 days provides objective confirmation or refutation. That’s the difference between assuming an intervention is working and actually knowing.
The same logic applies to exercise program changes. Adding regular resistance training to a mostly sedentary lifestyle should produce measurable HbA1c improvement within three to six months, reflecting improved insulin sensitivity from increased muscle mass and regular GLUT4 activation. If HbA1c hasn’t moved after three months of genuinely consistent resistance training, either the training volume or intensity was insufficient, or dietary factors are overriding the exercise benefit, or both — information that redirects the intervention.
Sleep improvement is another intervention where HbA1c tracking gives objective feedback. Moving from consistently inadequate sleep (five to six hours) to adequate sleep (seven to eight hours) should produce measurable HbA1c improvement within three to four months, independent of dietary or exercise changes. Improved sleep with no HbA1c movement? Look carefully at whether diet is the primary driver — sometimes sleep improvement gets partially neutralized by caloric compensation, eating more because more hours are awake and subjectively there’s more energy.
The behavioral feedback loop of regular HbA1c testing combined with specific intervention tracking turns the test from a passive diagnostic measure into an active performance metric. Nobody’s waiting for a doctor to say something’s wrong. The test becomes a tool for actively steering a biological system that’s still within reach to direct.
Connecting HbA1c to the Full Metabolic Health Stack
HbA1c doesn’t exist in isolation — it connects to and gets shaped by every other metabolic variable described across this article cluster. Understanding these connections turns the number from a clinical data point into a systems-level signal.
High HbA1c with high fasting insulin means insulin resistance is driving the glucose elevation — the pancreas is working hard, compensation is happening, and the primary target is reducing insulin resistance through diet, exercise, weight loss. High HbA1c with low fasting insulin means beta cell function is impaired — the pancreas is failing to respond adequately — a more advanced state that needs more aggressive management and potentially medical intervention beyond lifestyle changes alone.
HbA1c paired with CGM data gives the most complete glucose picture available: the quarterly average tells the cumulative story, the continuous trace tells the daily patterns driving that average. The combination shows whether a modestly elevated HbA1c reflects many small, frequent spikes (addressable through food order and fiber changes), a few large infrequent spikes (addressable through dietary composition changes), or a persistently elevated baseline (suggesting hepatic insulin resistance that needs the full insulin resistance reversal protocol).
Think of HbA1c as the final summary metric of a system with multiple inputs. Exercise, sleep, diet, stress, body composition — each shapes the HbA1c result through its effect on insulin sensitivity, glucose disposal capacity, hepatic glucose production, postprandial glucose management. Improving the number requires improving the inputs. Knowing which inputs are most impaired in a given situation — revealed by the companion tests and CGM data throughout this cluster — determines which interventions to prioritize. That’s the full picture. That’s how the number gets used.
Michael’s 5.6% wasn’t fine, and it wasn’t terrifying. It was information. A note from his own biology, written in the chemistry of glycated hemoglobin, telling him the trajectory of the past few years was headed the wrong direction. He could dismiss it, the way his doctor effectively did. Or he could use it as the data point it was, build a concrete plan, and retest in 90 days with evidence the plan was working. He chose the latter. Six months later, his HbA1c was 5.2%. His biology wrote a different note. He knew how to read it now.
The HbA1c Test: Practical Considerations for Getting and Interpreting Results
Knowing when and how to get an HbA1c test, and how to interpret the result with real nuance, means understanding several practical considerations rarely covered in standard patient guidance.
There’s no need to wait for an annual physical to test HbA1c. Direct-to-consumer lab services (LabCorp Patient, Quest MyQuest, EverlyWell, LetGetChecked) allow HbA1c testing without a physician referral for under $30-50, results back within days. For anyone doing active metabolic optimization, quarterly self-directed testing is feasible at this cost and delivers the data frequency needed to track intervention responses adequately.
Consistency in testing conditions matters for tracking trends accurately. HbA1c doesn’t require fasting, but testing at roughly the same time of year and with the same lab method each time cuts variability from seasonal blood volume changes and inter-laboratory methodological differences. Switching from Lab A to Lab B after three years of tracking means recognizing reference range boundaries and calibration may differ slightly — a concurrent parallel test before relying on Lab B results to interpret trends against Lab A history is the smart move.
Some people notice their HbA1c results shift slightly between tests done a few weeks apart, with no obvious explanation. This reflects the test’s inherent biological variability — small differences (0.1-0.2%) between sequential tests shouldn’t be over-interpreted. A meaningful HbA1c change generally means 0.3% or more, absent hemoglobin-related confounders. Obsessing over 0.1% differences is misusing the test’s precision. It’s a population-level calibrated estimate, not a molecular measurement of personal glycation rate with zero error margin.
Finally, bring the data to physician appointments. A printed record of HbA1c values across multiple years, alongside fasting glucose, fasting insulin, and triglycerides, gives a physician context a single current-year data point can’t provide. The conversation shifts from “your HbA1c is 5.6%, that’s normal” to “my HbA1c was 5.0% four years ago, 5.3% two years ago, and 5.6% now — that’s a clear upward trend that warrants intervention now, not at 5.7%.” The data makes that conversation possible. Without it, both sides are operating in the dark.
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map